Search

everythinglearnresearchcommunity

for

Search:↓

Scientists have created a new hair loss treatment using ultrasound to deliver gene-editing particles, which resulted in up to 90% hair regrowth in mice.

DNMT1 may help treat hypospadias by improving cell function and preventing unwanted cell changes.

SRD5A2 gene variations affect PTSD symptoms differently in males and females.

*Laportea bulbifera* contains unique compounds that may help treat benign prostatic hyperplasia.

Finasteride reduces DHT levels and affects gene expression in fish, similar to its effects in humans.

Baicalin may effectively treat hair loss by inhibiting 5α-reductase.

Male pattern baldness may be linked to prostate cancer risk.

Some prostate cancers have gene changes that may affect treatment with certain drugs.

The research gives new understanding on how human steroid 5α-reductases work and how drugs like finasteride inhibit them, which could help in creating new drugs.

Higher SRD5A2 expression predicts better response to finasteride in treating urinary symptoms.

Xiaozhi Yufa decoction may help treat hair loss by improving hair growth and reducing inflammation.

No consistent link between genotype and phenotype in 5-α-Reductase type 2 deficiency.

A rare gene variant causes sexual development issues in siblings, needing personalized treatment.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

Efficient enzyme function relies on specific residue interactions and structural coordination.

Finasteride's sexual side effects not caused by androgen deficiency or SRD5A inhibition.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

Manipulating 5α-reductase type 2 can affect liver fat production and glucocorticoid effects.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Plumbago zeylanica extract helps hair growth and reduces a hair loss-related enzyme.

Advancements in nanoformulations for CRISPR-Cas9 genome editing can respond to specific triggers for controlled gene editing, showing promise in treating incurable diseases, but challenges like precision and system design complexity still need to be addressed.

Higher childhood DHEAS levels are linked to advanced puberty and DNA changes.

5α-reductase deficiency can cause ambiguous genitalia and gender dysphoria, treatable with testosterone.

Personalized treatments for hair loss are becoming more effective by using genetic information.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

Adding Triamcinolone to the anesthetic can reduce swelling after hair transplants, and using Platelet-Rich Plasma can improve hair thickness and patient satisfaction. The SRD5A2 gene also plays a key role in the success of hair transplants.

Male-pattern hair loss is largely influenced by genetics, with key genes identified.

SRD5A2 enzyme expression varies in benign prostates and can be influenced by inflammation, affecting treatment options.

Steroid 5α-reductase evolved from protists and diversified in eukaryotes, with specific roles in mammals and plants.